Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction]
Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L. Cancer Manag Res. 2018;10:4371-4380. The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised regarding the alleged duplication of western blot bands in Figure 2 with those from another unrelate...
Main Authors: | Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-non-coding-rna-neat1mir-214-3p-contribute-to-doxorubicin-re-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
by: Alexander Chehrazi-Raffle, et al.
Published: (2021-02-01) -
Immunohistochemical expression of β-Catenin in urinary bladder urothelial carcinoma
by: Fatma-Elzhraa A. Sherkawy*, et al.
Published: (2021-01-01) -
Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction]
by: Wang Z, et al.
Published: (2022-06-01) -
Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties
by: Rocío Jiménez-Guerrero, et al.
Published: (2021-12-01) -
Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer
by: Junhao Zhou, et al.
Published: (2021-12-01)